Dmitry Balyasny’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding EWTX
BBA
Dmitry Balyasny's EWTX Position: Q3 2026 in Review
Dmitry Balyasny opened a new position in Edgewise Therapeutics (EWTX) in Q3 2026: 949,150 shares worth $38.5M. The stake represents 0.05% of the portfolio and ranks #496 among its holdings. This is a return to the name: Dmitry Balyasny previously reported a position in EWTX as recently as Q4 2025.
Dmitry Balyasny first reported a position in EWTX in Q4 2022 and has held it in 8 quarters since. 249 funds tracked by Wall St. Rank hold EWTX as of Q3 2026.
- Dmitry Balyasny held 949,150 shares of Edgewise Therapeutics worth $38.5M as of Q3 2026.
- Edgewise Therapeutics was a new Dmitry Balyasny position in Q3 2026.
- Edgewise Therapeutics made up 0.05% of Dmitry Balyasny's portfolio in Q3 2026, its #496 holding.
- Dmitry Balyasny first reported a position in Edgewise Therapeutics in Q4 2022 and has held it in 8 quarters since.
- 249 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q3 2026.
Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.